Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion
PositiveU.S News

In a significant move for the consumer health sector, Kimberly-Clark has announced its acquisition of Kenvue, the maker of Tylenol, in a deal valued at $48.7 billion. This merger is set to create a powerhouse in health goods, combining resources and expertise to better serve consumers. The acquisition not only strengthens Kimberly-Clark's portfolio but also positions it to compete more effectively in the growing health market, which is crucial as demand for health-related products continues to rise.
— Curated by the World Pulse Now AI Editorial System

